Bank Pictet & Cie (Asia)’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,090
Closed -$1.53M 94
2022
Q1
$1.53M Hold
6,090
0.41% 45
2021
Q4
$1.56M Hold
6,090
0.37% 56
2021
Q3
$1.48M Sell
6,090
-2,575
-30% -$630K 0.41% 48
2021
Q2
$1.79M Buy
8,665
+117
+1% +$23.8K 0.5% 30
2021
Q1
$1.61M Buy
8,548
+743
+10% +$131K 0.5% 33
2020
Q4
$1.28M Sell
7,805
-1,807
-19% -$264K 0.4% 39
2020
Q3
$1.2M Sell
9,612
-200
-2% -$24.8K 0.46% 27
2020
Q2
$952K Buy
9,812
+3,679
+60% +$382K 0.41% 43
2020
Q1
$551K Hold
6,133
0.27% 65
2019
Q4
$907K Hold
6,133
0.39% 56
2019
Q3
$739K Hold
6,133
0.33% 62
2019
Q2
$829K Hold
6,133
0.38% 57
2019
Q1
$800K Sell
6,133
-2,174
-26% -$292K 0.38% 53
2018
Q4
$1.03M Hold
8,307
0.56% 27
2018
Q3
$1.16M Sell
8,307
-4,802
-37% -$598K 0.53% 26
2018
Q2
$1.34M Buy
+13,109
New +$1.33M 0.62% 32
2015
Q3
Sell
-3,290
Closed -$298K 49
2015
Q2
$298K Buy
+3,290
New +$264K 1.01% 27

Other funds holding HCA

Bank Pictet & Cie (Asia)'s HCA Position: Q2 2022 in Review

Bank Pictet & Cie (Asia) sold out of HCA Healthcare (HCA) in Q2 2022, closing a stake of 6,090 shares — an estimated $1.53M sold.

Bank Pictet & Cie (Asia) first reported a position in HCA in Q2 2015 and held it in 17 quarters. The position peaked at $1.79M in Q2 2021. 884 funds tracked by Wall St. Rank hold HCA as of Q2 2022.

  • Bank Pictet & Cie (Asia) reported no remaining HCA Healthcare position as of Q2 2022 after selling out during the quarter.
  • Bank Pictet & Cie (Asia) sold 6,090 HCA Healthcare shares in Q2 2022, an estimated $1.53M.
  • Bank Pictet & Cie (Asia) first reported a position in HCA Healthcare in Q2 2015 and held it in 17 quarters.
  • Bank Pictet & Cie (Asia)'s HCA Healthcare position peaked at $1.79M in Q2 2021.
  • 884 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2022.

Based on Bank Pictet & Cie (Asia)'s 13F filing for Q2 2022, filed 5 Aug 2022.